Clarithromycin inhibits rhinovirus-induced bacterial adhesions to nasal epithelial cells

Laryngoscope

Volumn 120, Issue 1, 2010, Pages 193-199

  Wang, Jong Hwan ^a   Lee, Si Hyeong ^a   Kwon, Hyun Ja ^a   Jang, Yong Ju ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cell adhesion molecule; Clarithromycin; Common cold; Haemophilus influenzae; Human nasal epithelial cells; Rhinovirus; Staphylococcus aureus

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CLARITHROMYCIN; FIBRONECTIN; ANTIINFECTIVE AGENT; CELL ADHESION MOLECULE;

ARTICLE; BACTERIUM ADHERENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; EPITHELIUM CELL; FLUORESCENCE ANALYSIS; GENE EXPRESSION REGULATION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; IMAGING SYSTEM; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOVIRUS; RHINOVIRUS INFECTION; STAPHYLOCOCCUS AUREUS; VIRUS STRAIN; WESTERN BLOTTING; CELL CULTURE; DRUG EFFECT; MICROBIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; CLARITHROMYCIN; FIBRONECTINS; HAEMOPHILUS INFLUENZAE; HUMANS; NASAL MUCOSA; POLYMERASE CHAIN REACTION; RHINOVIRUS; STAPHYLOCOCCUS AUREUS;

EID: 74049136575     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20670     Document Type: Article

References (23)

1. Winther B, Gwaltney JM Jr, Mygind N, Hendley JO. Viralinduced rhinitis. Am J Rhinol 1998;12:17-20.
2. Wang JH, Kwon HJ, Chung YS, Lee BJ, Jang YJ. Infection rate and virus-induced cytokine secretion in experimental rhinovirus infection in mucosal organ culture: comparison between specimens from patients with chronic rhinosinusitis with nasal polyps and those from normal subjects. Arch Otolaryngol Head Neck Surg 2008;134:424-427.
3. Hauck CR, Agerer F, Muenzner P, Schmitter T. Cellular adhesion molecules as targets for bacterial infection. Eur J Cell Biol 2006;85:235-242.
4. Wang JH, Kwon HJ, Jang YJ. Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously. Laryngoscope 2009;119:1406-1411.
5. Gern JE, French DA, Grindle KA, Brockman-Schneider RA, Konno S, Busse WW. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am J Respir Cell Mol Biol 2003;28:731-737.
6. Hewson CA, Jardine A, Edwards MR, Laza-Stanca V, Johnston SL. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol 2005;79:12273-12279.
7. Sugiura H, Ichikawa T, Koarai A, et al. Activation of Tolllike receptor 3 augments myofibroblast differentiation. Am J Respir Cell Mol Biol 2009;40:654-662.
8. Muenzner P, Billker O, Meyer TF, Naumann M. Nuclear factor-kappa B directs carcinoembryonic antigen-related cellular adhesion molecule 1 receptor expression in Neisseria gonorrhoeae-infected epithelial cells. J Biol Chem 2002;277:7438-7446.
9. Ichiyama T, Nishikawa M, Yoshitomi T, et al. Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob Agents Chemother 2001;45:44-47.
10. Wallwork B, Coman W, Feron F, Mackay-Sim A, Cervin A. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope 2002;112: 1827-1830.
11. Matsune S, Sun D, Ohori J, et al. Inhibition of vascular endothelial growth factor by macrolides in cultured fibroblasts from nasal polyps. Laryngoscope 2005;115: 1953-1956.
12. Miyanohara T, Ushikai M, Matsune S, Ueno K, Katahira S, Kurono Y. Effect of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope 2000; 110:126-131.
13. Jang YJ, Wang JH, Kim JS, Kwon HJ, Yeo NK, Lee BJ. Levocetirizine inhibits rhinovirus-induced ICAM-1 and cytokine expression and viral replication in airway epithelial cells. Antiviral Res 2009;81:226-233.
14. Jang YJ, Kwon HJ, Lee BJ. Effect of clarithromycin on rhinovirus-16 infection in A549 cells. Eur Respir J 2006;27: 12-19.
15. Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-738.
16. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003;301:640-643.
17. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511.
18. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.
19. Patel KB, Xuan D, Tessier PR, Russomanno JH, Quintiliani R, Nightingale CH. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob Agents Chemother 1996;40:2375-2379.
20. Pitkaranta A, Arruda E, Malmberg H, Hayden FG. Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR. J Clin Microbiol 1997;35:1791-1793.
21. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114:155-212.
22. Damm M, Quante G, Jurk T, Sauer JA. Nasal colonization with Staphylococcus aureus is not associated with the severity of symptoms or the extent of the disease in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2004;131: 200-206.
23. Osur SL. Viral respiratory infections in association with asthma and sinusitis: a review. Ann Allergy Asthma Immunol 2002;89:553-560.